MDxHealth (R): SelectMDx improves prostate biopsy decision-making in urology practices

Go back to MDxHealth (R): SelectMDx improves prostate biopsy decision-making in urology practices
(NASDAQ: MDXH) Delayed: 0.16 --0 (-0%)
Previous Close $0.16    52 Week High $ 
Open $0.16    52 Week Low $ 
Day High $0.17    P/E N/A 
Day Low $0.16    EPS $ 
Volume 192,042